Latest Posts

• ICER, CRISPR, Biotech Activism & More: The X of the Year Finalists

  With so many stellar Xconomy Award nominees this year, we wanted to recognize several who don’t fit neatly into the other categories, so we’ve created categories just for them. One of these nominees for X of the Year is gaining influence... Read more »

  Corie Lok8/15/18

• Fidelity Vets Launch Castle Island Ventures, a $30M Blockchain Fund

  There’s a new venture fund in town, focused on the hypiest of hyped sectors right now: blockchain systems and cryptocurrencies. It’s a small fund, but what’s interesting about Castle Island Ventures is the pedigree of the Boston firm’s founders and the... Read more »

  Jeff Engel8/15/18

• SF’s Full Harvest Bags $8.5M to Help Sell “Ugly and Surplus” Produce

  Full Harvest, an online market for imperfect produce that previously would have been thrown out, announced it has raised $8.5 million in a Series A round of funding.

  The funding was led by Spark Capital and includes investors such as Cultivian... Read more »

  Angela Shah8/15/18

• State DOT Director Replaces CEO of American Center for Mobility 

  The American Center for Mobility, the Ypsilanti Township, MI-based public-private entity developing and testing advanced automotive technologies, announced this week that it has parted ways with John Maddox, its president and CEO.

  Taking the helm on an interim basis is... Read more »

  Sarah Schmid Stevenson8/15/18

• Goal of Epic Summit for Non-Clients Is Better Health Records Sharing

  For years, the patient records software company Epic Systems has held an annual conference, which attracts thousands of leaders from hospitals and clinics that use Epic’s software to the company’s headquarters in Verona, WI.

  The customer conference, known as Users... Read more »

  Jeff Buchanan8/14/18

• Marketer AdSwerve to Pay $24M for Analytics Pros’ Google Knowhow

  Seattle-based Analytics Pros has sold to another Google-focused marketing company, Denver, CO-based AdSwerve, for $24 million in a private equity-backed deal, according to a company spokesman.

  Boston-based Abry Partners funded the acquisition, and Analytics Pros will “transition” into AdSwerve in January... Read more »

  David Holley8/14/18

• Exabeam Raises $50M, Says It’s Gaining On Big Rival Splunk

  Exabeam, a cybersecurity company that analyzes activity logs and other data generated by computers and devices as it scans for potential threats, announced today that it raised $50 million in a Series D funding round.

  San Mateo, CA-based Exabeam is... Read more »

  Bernadette Tansey8/14/18

• From Robots to Golf, Indy Group Gets Creative to Boost Women in Tech

  The tech industry’s efforts to recruit more girls and women to the field are still falling short, despite the priority being placed on STEM (science, technology, engineering, and math) education in K-12 schools. That’s the conclusion reached in a study released... Read more »

  Sarah Schmid Stevenson8/14/18

• Ford’s Autonomic Pairs With Alibaba Cloud On Mobility Hub for China

  Ford—one of the automakers competing in China’s huge car market—is now making a bid to provide China’s leading software infrastructure hub dedicated to streamlining transportation by connecting cars and riders with mobility services.

  Ford’s recently acquired unit Autonomic, which co-created... Read more »

  Bernadette Tansey8/14/18

• New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs

  A new biotech company, Magnolia Neurosciences, is launching with $31 million from investors to develop potential therapies for nervous system disorders based on discoveries at the University of Texas MD Anderson Cancer Center.

  Magnolia, which is based in New York, was... Read more »

  Angela Shah8/13/18

• Digital Tools, Online Community & More: Patient Partnership Award Finalists

  Patients are supposed to be at the center of medicine, but the sheer size and complexity of the healthcare and life science industries often makes it challenging to maintain focus on patients. The finalists in this year’s Patient Partnership category of... Read more »

  Corie Lok8/13/18

• Fresh Off GSK Deal, Gene Therapy Startup Orchard Bags Another $150M

  Another gene therapy startup looks primed for an IPO. Orchard Therapeutics has just landed another $150 million to help drive forward a group of gene therapies it bought from British pharma company GlaxoSmithKline earlier this year.

  The Series C funding round... Read more »

  Ben Fidler8/13/18

• Race for Governor, Foxconn, Promega & More: This Week’s WI Watchlist

  Voters in Wisconsin will head to the polls on Tuesday, Aug. 14 to cast ballots in primary races for governor and other elected offices. Read on to learn about connections between some of the candidates for governor and the state’s technology... Read more »

  Jeff Buchanan8/10/18

Load More News ›

• Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals

  [Updated, 8/13/18, see below] The FDA has approved a new treatment for Fabry disease, a decision that represents the end of a winding, more than decade-long saga for the drug’s developer, Amicus Therapeutics. Its long journey also highlights how... Read more »

  Ben Fidler8/10/18

• Exits in Austin, Pitch NASA, Diversity in Energy, & More TX Tech

  Let’s catch up with the latest innovation news from Texas.

  —Accruent, an Austin-based maker of resource management software, is being acquired by Fortive (NYSE: FTV) for about $2 billion in cash, according to a press release. Fortive, which is... Read more »

  Angela Shah8/10/18

• Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug

  [Updated at 4:08 pm ET, see below] Alnylam Pharmaceuticals made history this afternoon.

  The FDA has just approved Alnylam’s patisiran (Onpattro), making it the first medicine specifically cleared to treat a rare and deadly disease called hereditary transthyretin... Read more »

  Ben Fidler8/10/18

• Fifth Eye Scores $2.3M for Software to Detect Patient Warning Signs

  [Update, 2:02 p.m., see below.] Jen Baird, a serial entrepreneur who has led several Michigan-based healthcare technology startups, is back at it with Fifth Eye, an Ann Arbor, MI-based company developing software that performs analytics on patient... Read more »

  Sarah Schmid Stevenson8/10/18

• Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

  Two imminent FDA rulings on two separate drugs aren’t just noteworthy for the patients they’ll help, but the long and winding road their developers have taken to get to this point.

  First is Alnylam Pharmaceuticals, which has spent 16 years and... Read more »

  Ben Fidler8/10/18

• Boston Tech Watch: Drizly, Skyworks, Polaris, Akili, Kebotix & More

  [Updated 8/10/18, 1:33 pm. See below.] Time to catch up on some of the latest deals and developments in the Boston-area tech sector:

  —Skyworks Solutions (NASDAQ: SWKS), the Woburn, MA-based chipmaker, said it inked a deal to acquire... Read more »

  Jeff Engel8/10/18

• You’ve Got Mail: Earth Class Mail Revamps After New Execs Take Over

  San Antonio—Earth Class Mail, a 14-year-old company that digitizes snail mail for businesses, has announced a few upgrades to its product, including search features, the ability to share content over e-mail, and custom tags, among others.

  The new look and... Read more »

  David Holley8/9/18

• Austin Group Joins Other Tech Efforts to Promote Responsible AI Use

  Artificial intelligence is poised to infiltrate nearly all aspects of human life. Given this development, technologists are focusing on how to ensure the technology usage is governed by ethics.

  “The general rule is that power begets responsibility,” says Michael Stewart, founder... Read more »

  Angela Shah8/9/18

• Midwestern BioAg CEO: Organic Label About Marketing, Not Nutrition

  Midwestern BioAg has been in business for more than three decades, and during that time it has worked with thousands of farmers to implement the Madison, WI-based company’s recommended soil and crop care practices on about four million acres of farmland,... Read more »

  Jeff Buchanan8/9/18

Load More News ›

• Millendo Therapeutics Goes Public With OvaScience Reverse Merger

  [Corrected 2:30 p.m. See below.] Millendo Therapeutics, an Ann Arbor, MI-based biotech company developing drugs to treat endocrine diseases, is now a public company and has $30 million of new cash to continue work on its treatments for rare... Read more »

  David Holley8/9/18

• ACM Report: AVs May be Less Disruptive to Trucking Jobs Than Expected

  The advent of autonomous vehicles is expected to drastically change the transportation industry and affect those who work in it, but perhaps not as significantly as once thought, according to a new report commissioned by the American Center for Mobility.... Read more »

  Sarah Schmid Stevenson8/9/18

• Inclusion in Labs, the C-Suite & More: Xconomy Awards Diversity Finalists

  Efforts to boost diversity and inclusion at life science organizations are themselves becoming more diverse. A growing number of biotech companies are adjusting their recruitment and hiring practices to ensure that their employee rosters—from the lab to the boardroom—better reflect the... Read more »

  Frank Vinluan8/9/18

• Inari Agriculture Harvests $40M to Ramp Up Gene Editing R&D

  Less than one month after emerging from stealth, ag biotech startup Inari Agriculture is unveiling $40 million in capital to accelerate its work on gene-editing for crop breeding.

  The Series B round of financing for Cambridge, MA-based Inari adds Acre Venture... Read more »

  Frank Vinluan8/9/18

• Domino Data Lab Raises $40M To Manage Clients’ Predictive Models

  [Updated 8/8/18, 4:40 pm. See below.] Domino Data Lab, which provides a test bed to aid in the development of predictive models, as well as tools to monitor models in use, announced today it has raised $40 million... Read more »

  Bernadette Tansey8/8/18

• Yesware Hauls In $15M and Replaces Founding CEO

  It’s the end of an era for Yesware, an eight-year-old maker of e-mail software for salespeople. The Boston-based startup announced Wednesday that it brought in $15 million in venture capital, but the bigger news is that co-founder and CEO Matthew Bellows... Read more »

  Jeff Engel8/8/18

• Paratek Eyes FDA Approval of Antibiotic After Advisory Panel Nod

  An FDA advisory committee voted to recommend U.S. approval of Paratek Pharmaceuticals’ experimental antibiotic, omadacycline, both for the treatment of certain types of bacterial skin infections and hospital-acquired pneumonia.

  The independent advisory panel’s endorsement isn’t binding, but the FDA often follows... Read more »

  Jeff Engel8/8/18

• CVS, Teladoc Offering $59 Virtual Health Visits for Minor Conditions

  CVS Health on Wednesday introduced a new telemedicine service for people with minor illnesses and injuries, which the Rhode Island-based pharmacy giant says will allow patients in nine U.S. states and Washington, D.C., to pay $59 for an online videoconference with... Read more »

  Jeff Buchanan8/8/18

Read More Posts ›